Pegylated interferon-associated retinopathy in chronic hepatitis C patients [6]

Japanese Journal of Ophthalmology

Volumn 50, Issue 3, 2006, Pages 293-294

  Ogata, Hiroko ^a   Suzuki, Hiromasa ^a   Shimizu, Kimiya ^a   Ishikawa, Hitoshi ^a   Izumi, Namiki ^b   Kurosaki, Masayuki ^b  

^a KITASATO UNIVERSITY   (Japan)

^b MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Interferon; Interferon associated retinopathy; Pegylated interferon; Retinopathy

Indexed keywords

INTERFERON; PEGINTERFERON;

ADULT; AGED; ANEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS C VIRUS; HUMAN; LETTER; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINOPATHY; THROMBOCYTOPENIA; VIRUS INFECTION; VISUAL ACUITY;

EID: 33745085930     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-005-0301-1     Document Type: Letter

References (5)

1. Y Kondo R Tateishi H Yoshida M Omata 2004 Effectiveness of long-acting interferon (peginterferon) Nippon Rinsho (Jpn J Clin Med) 62 515 518
2. S Zeuzem SV Feinman J Rasenack 2000 Peginterferon alpha-2a in patients with chronic hepatitis C N Eng J Med 343 1666 1672
3. T Chuman N Naoi A Sawada T Kawano M Shigehira 1994 Interferon-induced retinal changes Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn) 98 616 621
4. K Miyamoto T Suda M Motokura 1993 Retinopathy in interferon-α treatment Atarashii Ganka (J of the Eye) 10 497 500
5. Ahmed F, Jacobson IM, Chen ST, et al. (abstract 1196) Serious ophthalmologic events during pegylated interferon and ribavirin therapy for chronic hepatitis C: observations from the WIN-R trial. American Association for the Study of Liver Disease. Boston, Massachusetts. 2003;38:734-735